Unless stated all financials at 31 March 2026
£1.04bn
Net assets
170.6p
NAV per share
(0.2)%
NAV per share return in the 12 months
£839m
Value of life science portfolio
1.7%
Return from life science portfolio in the 12 months
£198m
Capital pool